Apply to trial NCT07505771

A few quick questions so the study team can decide if you might be a fit.

RecruitingEarly Phase 1Drug trial

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

IM-3050-101 is a Phase 1 study to determine the safety and effectiveness of 177Lu-IM-3050 in treating participants with advanced cancer.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.